FDA Deems Mircera “Approvable” For Anemia Pending Cardio-Renal Committee Outcome
This article was originally published in The Pink Sheet Daily
Executive Summary
No further clinical trials involving the long-acting erythropoiesis-stimulating agent are anticipated, Roche says.